Navigation Links
Breast Cancer Action Sues to End Gene Patenting
Date:5/12/2009

Lawsuit Seeks Increased Access to Information for Patients of Breast Cancer

SAN FRANCISCO, May 12 /PRNewswire-USNewswire/ -- Breast Cancer Action (BCA) is challenging the legality of patenting human "breast cancer genes." BCA is joining the American Civil Liberties Union in suing Myriad Genetics (a private biotechnology company based in Utah), that currently holds the patent on the two human genes known as BRAC1 and BRAC2.

The BRAC1 and BRAC2 genes are present in every human. However, people with certain genetic mutations on these genes are at an increased risk of developing breast and ovarian cancer. Myriad holds exclusive rights to these genes and their mutations and to the research performed on them. Testing for the BRAC1 and BRAC2 mutations can only be performed at Myriad labs and currently costs over $3,000.

Since 1998, when BRAC1 & 2 were first patented, BCA has maintained that the patenting of human genes interferes with patients' access to genetic testing and medical care.

"The time has finally arrived for the courts to decide who owns our genes," said Barbara Brenner, executive director of Breast Cancer Action.

When one company controls all the testing, less information and resources are available to both patients and researchers. Women unable to afford the $3,500 fee are prevented from access to the test; women seeking second opinions on any results they might receive have nowhere to go; and women of African, Hispanic, or Asian decent are at a significant disadvantage because they disproportionately receive ambiguous results when tested by Myriad.

"There are so many injustices and inequities in breast cancer," Brenner said. "The time has come to address them in all their forms -- as they affect genetic risk, as well as social, political, and economic realities. This case is an important first step."

BCA joins this litigation in hopes that it will open doors to better research and information, and ultimately better health care for women regardless of their economic situation or their racial background.

The case, Association for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al., is filed in the U.S District Court for the Southern District of New York.

Breast Cancer Action (www.bcaction.org) -- is a non-profit education and advocacy organization that does not accept funding from pharmaceutical companies or any other organizations that profit from or contribute to the breast cancer epidemic.


'/>"/>
SOURCE Breast Cancer Action
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ACMG Joins Lawsuit Challenging Patents on Breast Cancer Genes; Genes Are Naturally Occurring Substances and Should Not Be Patented, Says American College of Medical Genetics
2. ACLU Challenges Patents on Breast Cancer Genes
3. Scientists identify gene in breast cancer pathway
4. MultiVu Video Feed: REESE WITHERSPOON JOINS AVON FOUNDATION FOR WOMEN AND SAN FRANCISCO GENERAL HOSPITAL TO CELEBRATE 5TH ANNIVERSARY OF AVON COMPREHENSIVE BREAST CENTER
5. Video: Reese Witherspoon Joins Avon Foundation for Women and San Francisco General Hospital to Celebrate 5th Anniversary of Avon Comprehensive Breast Center
6. HealthCentral.com Collaborates With BreastCancer.org, Providing Quality Awareness Sponsorships to #1 Breast Cancer Resource Online
7. Park Meadows Cosmetic Surgery, a Pioneer in DIEP Flap Breast Reconstruction Surgery in Colorado, Introduces New, Informative Website
8. International Breast Milk Project Helps Mothers Worldwide
9. New technique may help detect potential breast cancer spread
10. Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer
11. Genes Linked to Spread of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... , ... Bellus Medical, a leader in medical aesthetics, recently ... of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated ... and minimize the appearance of pores – all with minimal downtime and results ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... Ariz. (PRWEB) , ... April 25, 2017 , ... Emergency ... latest book of the Outlier Leadership Series, Outliers in Writing, set to publish in ... Professor of Emergency Medicine at the University of Arizona College of Medicine. He also ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WARSAW, Ind. , April 20, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Health Care Conference at the InterContinental Hotel in ... 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern ... can be accessed via Zimmer Biomet,s Investor Relations website ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: